Ceribell, Inc. (Nasdaq: CBLL), a commercial-stage medical technology company focused on transforming the diagnosis and ...

Ceribell rang in a $180.3 million IPO last week, with its public debut on the Nasdaq coming in well above its first pricing ...

The company’s upsized offering is a hopeful sign for venture investors in the sector.

EEG device maker CeriBell, known for its brain-monitoring headband, made its debut on the Nasdaq today in a closely watched ...

Ceribell Inc., a medical-device maker that uses artificial intelligence to monitor patient seizures, was on track for a ...

CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, ...

CeriBell此次发行10,606,060股普通股，募资总额为1.8亿美元。 CeriBell首日开盘价为23.26美元，较发行价上涨36.8%；收盘价为25美元，较发行价上涨47%；以首日收盘价计算，公司市值为8.5亿美元。

CeriBell announced that it priced an upsized initial public offering (IPO), expecting proceeds of approximately $180.3 ...

CeriBell (NASDAQ:CBLL) shares rallied 35% Friday following the medical device maker’s $180M initial public offering. Shares ...

【ITBEAR】医疗诊断系统开发商CeriBell近日在美国纳斯达克成功上市，股票代码为“CBLL”，发行价定为17美元。此次上市，CeriBell共发行了10,606,060股普通股，募集资金总额达到1.8亿美元。

Recent strong debuts by weight-loss drug developer BioAge Labs and TPG-backed cancer therapy developer Bicara Therapeutics, ...

Ceribell shares were higher in their Nasdaq debut after an upsized initial public offering priced at the high end of a projected range. Shares of Ceribell, maker of an AI-powered brain monitoring ...